v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Shares outstanding, beginning balance (in shares) at Dec. 31, 2024   155,928      
Equity, beginning balance at Dec. 31, 2024 $ 188,762 $ 1,559 $ 971,416 $ (58,975) $ (725,238)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 4,242   4,242    
Net loss (16,239)       (16,239)
Exercise of stock options (in shares)   10      
Preferred dividends and accretion (891)   (891)    
Other comprehensive income 26,065     26,065  
Shares outstanding, ending balance (in shares) at Mar. 31, 2025   155,938      
Equity, ending balance at Mar. 31, 2025 201,939 $ 1,559 974,767 (32,910) (741,477)
Shares outstanding, beginning balance (in shares) at Dec. 31, 2024   155,928      
Equity, beginning balance at Dec. 31, 2024 188,762 $ 1,559 971,416 (58,975) (725,238)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (48,148)        
Shares outstanding, ending balance (in shares) at Jun. 30, 2025   155,938      
Equity, ending balance at Jun. 30, 2025 183,906 $ 1,559 975,161 (19,428) (773,386)
Shares outstanding, beginning balance (in shares) at Mar. 31, 2025   155,938      
Equity, beginning balance at Mar. 31, 2025 201,939 $ 1,559 974,767 (32,910) (741,477)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 1,285   1,285    
Net loss (31,909)       (31,909)
Preferred dividends and accretion (891)   (891)    
Other comprehensive income 13,482     13,482  
Shares outstanding, ending balance (in shares) at Jun. 30, 2025   155,938      
Equity, ending balance at Jun. 30, 2025 $ 183,906 $ 1,559 975,161 (19,428) (773,386)
Shares outstanding, beginning balance (in shares) at Dec. 31, 2025 266,267 266,267      
Equity, beginning balance at Dec. 31, 2025 $ 250,370 $ 2,663 1,358,992 (18,213) (1,093,072)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 2,738   2,738    
Net loss (20,419)       (20,419)
Exercise of Penny warrants (in shares)   7,000      
Exercise of Penny Warrants 70 $ 70      
Issuance of stock under share-based compensation plans (in shares)   1,495      
Issuance of stock under share-based compensation plans 0 $ 15 (15)    
Tax withholding on stock option exercises (2,521)   (2,521)    
Issuance of shares to Trina for anti-dilution right (in shares)   4,275      
Issuance of shares to Trina for anti-dilution right 0 $ 42 (42)    
Reclassification of warrants from liability classified to equity classified 116   116    
Preferred dividends and accretion (990)   (990)    
Other comprehensive income 7,338     7,338  
Shares outstanding, ending balance (in shares) at Mar. 31, 2026   279,037      
Equity, ending balance at Mar. 31, 2026 $ 236,702 $ 2,790 1,358,278 (10,875) (1,113,491)
Shares outstanding, beginning balance (in shares) at Dec. 31, 2025 266,267 266,267      
Equity, beginning balance at Dec. 31, 2025 $ 250,370 $ 2,663 1,358,992 (18,213) (1,093,072)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (63,955)        
Shares outstanding, ending balance (in shares) at Jun. 30, 2026 280,604 280,604      
Equity, ending balance at Jun. 30, 2026 $ 201,779 $ 2,806 1,371,216 (15,216) (1,157,027)
Shares outstanding, beginning balance (in shares) at Mar. 31, 2026   279,037      
Equity, beginning balance at Mar. 31, 2026 236,702 $ 2,790 1,358,278 (10,875) (1,113,491)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 5,792   5,792    
Net loss (43,536)       (43,536)
Issuance of stock under share-based compensation plans (in shares)   1,567      
Issuance of stock under share-based compensation plans 16 $ 16      
Tax withholding on stock option exercises (1,297)   (1,297)    
Stock option exercises 6,817   6,817    
Reclassification of warrants from liability classified to equity classified 2,616   2,616    
Preferred dividends and accretion (990)   (990)    
Other comprehensive income $ (4,341)     (4,341)  
Shares outstanding, ending balance (in shares) at Jun. 30, 2026 280,604 280,604      
Equity, ending balance at Jun. 30, 2026 $ 201,779 $ 2,806 $ 1,371,216 $ (15,216) $ (1,157,027)